Skip To Main Content

Science at Sanofi

Discover a wide variety of articles, videos, podcasts, accredited courses, applications, conferences and scientific events in different therapeutic areas

Sort by

Filters

Reset
  • Therapeutical Areas
  • Type of Content

The Evolving Role of Treatment and Technology in Diabetes Care

Time-in-Range: A Key Determinant of Quality of Life

The ATOS Study: Real-World Study on Effectiveness of Insulin Glargine U300 in the Gulf Region.

What Are the Signs and Symptoms of ASMD?

Advancing Therapy with iGlarLixi: Differentiation from other complex regimens

An educational video outlining key data from indirect comparisons of iGlarLixi versus IDegAsp.

Gaucher

Navigating the Pompe Disease Journey

Recognizing Key Signs and Symptoms Along the Way

Better care for Fabry

Every Moment Matters on the Fabry Journey

EVOLUTION: RWE from Saudi Arabia

Challenges associated with commonly-used insulin advancement options

How To Diagnose LSDs?

Learn more about early diagnosis of lysosomal storage disorders: Fabry disease, Pompe Disease, Gaucher disease, Acid Sphingomyelinase Deficiency (ASMD, also known as Niemann-Pick Type A/B), mucopolysaccharidoses (MPSs).

Glargine 300 use in people with type 2 diabetes who fast during Ramadan

Watch Professor Mohamed Hassanein, consultant endocrinologist in Dubai Hospital, Dubai Health Authority and the chair of Diabetes and Ramadan International Alliance shedding the light on what are the unmet needs amongst Muslims with Type 2 diabetes when fast during Ramadan.